Back/Oracle embeds role-based AI agents across Fusion Cloud to automate enterprise workflows
tech·February 11, 2026·orcl

Oracle embeds role-based AI agents across Fusion Cloud to automate enterprise workflows

ED
Editorial
Cashu Markets·3 min read
TL;DR
  • Oracle embeds prebuilt role-based AI agents across Fusion Cloud, running on OCI and Agent Studio, with no extra license cost. • Oracle's agents use unified enterprise data to automate tasks, surface predictive signals, and speed decisions across sales, marketing, service. • Oracle faces securities class-action suits alleging it understated AI infrastructure spending impact; lead-plaintiff motions due early April.

Oracle embeds role-based AI agents across its Fusion cloud suites to drive workflow automation

Oracle is rolling out prebuilt, role-based AI agents embedded directly into its Fusion Cloud Applications, aiming to turn slow, reactive enterprise processes into proactive, revenue-driving workflows. Announced at the Oracle AI World Tour in Mumbai, the agents run on Oracle Cloud Infrastructure (OCI) and are built with Oracle AI Agent Studio; they are natively integrated into Oracle Fusion Cloud Customer Experience (CX) and other Fusion Applications at no additional licensing cost. The company says the agents use unified enterprise data to automate routine tasks, surface predictive signals and enable faster, more consistent decision-making across sales, marketing and service functions.

The marketing-focused agents include Program Planning, Program Brief and Program Orchestration agents that translate strategy into actionable tactics, plus Buying Group, Customer Insights and Audience Analysis agents that identify high-potential accounts and relevant signals such as billing status or renewal timing. Oracle positions these features as immediately available to Fusion customers and expects them to reduce manual work, shorten time-to-insight and improve pipeline conversion and customer retention. Chris Leone, head of Applications Development, frames the capability as a way for organizations to extract more value from unified data without disrupting existing workflows.

Oracle is extending the agent approach to supply chain and manufacturing, offering pre-trained agents for planning cycles, component replacement, autonomous sourcing and maintenance cost estimation, among others. Concurrently, Oracle introduces process-manufacturing enhancements — formula‑recipe‑batch synchronization, operation yield modeling and flexible batch execution — designed for regulated industries such as life sciences and food and beverage. The company emphasises OCI security, governance and scalability, and says customers should realise measurable productivity gains, fewer manual interventions and improved traceability as agents automate end-to-end business processes.

Hospitals migrate to OCI to support clinical AI pilots

Separately, multiple health providers are moving Oracle Health Foundation EHR workloads to OCI. A five-hospital Transform Shared Service Organization in Ontario reports a 71% average reduction in page-load times and is piloting Oracle Health Clinical AI Agent; Hillsboro Health in Illinois announces plans to adopt Oracle Health Foundation, Clinical AI Agent and Seamless Exchange to unify records and automate documentation.

Regulatory and investor scrutiny surfaces in two securities suits

Oracle faces at least two securities class-action filings alleging it understated the timing and revenue impact of increased AI infrastructure capital spending. Firms including Kessler Topaz and Levi & Korsinsky seek lead plaintiffs for actions linked to statements about data‑centre contracts and capex, with deadlines for motions to be appointed lead plaintiff in early April.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...